Upcoming Events

Keep up to date with the latest news and thought from the Crown Bioscience Team.

events-magnifyglass.png

AACR: New Horizons in Cancer Research Conference: Bringing Cancer Discoveries to Patients

October 25, 2015

AACR: New Horizons in Cancer Research Conference Bringing Cancer Discoveries to Patients

November 12-15, 2015

Booth 10

Shanghai Marriott Parkview Hotel, Shanghai, P.R. China.

Join us at the 2015 AACR New Horizons in Cancer Research Conference in Shanghai to hear about Crown Bioscience's Translational Platform for Oncology and Immunotherapeutics using the world's largest collection of PDX in Human Surrogate Trials (HuTrial™) to accelerate the successful translation of novel oncology therapies into the clinic, as well as the most comprehensive range of dedicated in vitro and in vivo services to power your oncology drug discovery projects. With a constantly growing, globally diverse collection of over 2,000 PDX, and 8,000 Tumor tissues, humanised models for immunotherapeutics, and the capacity to run 100s of models in parallel, let's talk about how we can help you accelerate the transition of your lead candidate into the clinic.

Click here to join our mailing list to be kept up to date with the latest on Crown, our models and Translational Platform. For more information about us and our services, contact us today. To arrange a meeting with our scientists in Shanghai, simply email us today at busdev@crownbio.com . Below is a list of the posters we will be presenting. If you would like to receive copies of these posters, please contact us at busdev@crownbio.com :

Abstract ID: A0087
Title: A novel RET TKI inhibits tumor growth in the patient derived xenografts with RET fusion and overcomes the Ponatinib induced resistance
Presenter name: Davy Xuesong Ouyang
Session: Poster Session A
Session Date and Time: 13:00-15:30, Friday, November 13, 2015
Session Location: Ballroom 1-3, Level 2
Permanent Abstract Number: No. 55

 

Abstract ID: A0095
Title: Establishment of a mouse breast cancer allograft model for in vivo pharmacological analysis of immunotherapy
Presenter name: Davy Xuesong Ouyang
Session: Poster Session B
Session Date and Time: 12:00-14:30, Saturday, November 14, 2015
Session Location: Ballroom 1-3, Level 2
Permanent Abstract Number:  No. 49

 

Abstract ID: A0103
Title: Establishment of humanized PD-1 mouse model for in vivo pharmacological evaluation of anti-human PD-1 antibodies
Presenter name: Zhun Wang
Session: Poster Session B
Session Date and Time: 12:00-14:30, Saturday, November 14, 2015
Session Location: Ballroom 1-3, Level 2
Permanent Abstract Number:  No. 48

 

Abstract ID: A0121
Title: Immunological characterization: allograft of primary murine breast cancer (MuPrimeTM) versus murine breast cancer cell derived syngeneic tumors
Presenter name: Dr. Bin Chen
Session: Poster Session A
Session Date and Time: 13:00 – 15:30, Friday, November 13, 2015
Session Location: Ballroom 1 – 3, Level 2
Permanent Abstract Number: No. 45

 

Abstract ID: A0035
Title: RNAseq and immune profiling analysis of syngeneic mouse models treated with immune checkpoint inhibitors enable biomarker discovery and model selection for cancer immunotherapy
Presenter name: Dr. Qian Shi
Session: Poster Session A
Session Date and Time:  13:00-15:30, Friday, November 13, 2015
Session Location: Ballroom 1-3, Level 2
Permanent Abstract Number:  No. 33

 

Abstract ID: A0036
Title:  Drug resistant murine tumor models facilitate development of next generation anticancer therapeutics
Presenter name: Dr. Qian Shi
Session: Poster Session A
Session Date and Time:  13:00-15:30, Friday, November 13, 2015
Session Location: Ballroom 1-3, Level 2
Permanent Abstract Number:  No. 34

Topics: Event